Not rendering correctly? View this email as a web page here.
Mewburn graphic

Building an Effective Drug Franchise:
A Transatlantic Perspective

April 23, 2019 | Boston, MA

It's never too early, or too late, to start thinking about managing the life cycle of exclusivity and getting the most value from your innovation. In this networking seminar, we will share real-life case studies and provide practical advice on maximizing the scope and duration of patent protection for your drug or clinical candidate in both US and European markets.

Join us on April 23rd to hear IP attorneys from Wolf Greenfield (US) and Mewburn Ellis (Europe) compare and contrast the patent strategies available to build a robust patent portfolio.


Sarah Kostiuk-Smith, European Patent Attorney, Chemistry Team, Mewburn Ellis
Hunter Baker, Chair, Pharmaceutical Group, Wolf Greenfield
Emily Hayes, European Patent Attorney, Life Sciences Team, Mewburn Ellis
Dan Young, Shareholder, Biotechnology Group, Wolf Greenfield



Tuesday, April 23rd, 2019
Registration 5:30-6:00pm
Program 6:00-7:30pm
Reception 7:30-8:30pm

Café ArtScience
650 E. Kendall Street
Cambridge, MA 02142

Francesca Householder
Jacqueline Murphy

Cocktail Bar II
Tel. 617.646.8000   
Tel. 212.697.7890   
This email contains Attorney Advertising. Prior results do not guarantee a similar outcome. You received this email because you are subscribed to Events from Wolf, Greenfield & Sacks, P.C..
Update your email preferences to choose the types of emails you receive.
Unsubscribe from all future emails